Skip to content

The efficacy of collagenated xenogenic block bone (A-Oss collagen) in peri-implantitis regenerative surgery compared with particulate xenogenic bone

The efficacy of collagenated xenogenic block bone (A-Oss collagen) in peri-implantitis regenerative surgery compared with particulate xenogenic bone: A single-center, single-blind, randomized controlled trial.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0007856
Enrollment
50
Registered
2022-10-26
Start date
2023-05-17
Completion date
Unknown
Last updated
2024-07-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Medical Device : The intervention groups consist of a test group applying a collagenated block type bone substitute (A-Oss Collagen) to the peri-implant defect and an active control group applying a p

Sponsors

Seoul National University Dental Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Subjects whose general condition is eligible for surgical treatment of peri-implantitis. 2. Subjects who have undergone nonsurgical treatment of peri-implantitis within the last 3 months, but the lesion has not been resolved. 3. Implant prosthesis can be removed. 4. Subjects with intrabony defects around implants on radiographs. 5. peri-implant bone loss on radiograph: 6 mm or less on radiographs. 6. Subjects who voluntarily consent to the clinical trial and are willing to comply with the protocol

Exclusion criteria

Exclusion criteria: 1. Acute infection at the site where peri-implantitis is present. 2. Extensive bone loss due to peri-implantitis and/or periodontitis that requires extraction of adjacent teeth. 3. Pregnant or lactating women. 4. Uncontrolled metabolic systemic disease (hypertension, diabetes). 5. A history of radiation therapy and chemotherapy in the head and neck area. 6. Complications of serious cardiovascular disease, respiratory system disease, kidney disease, liver disease, digestive system disease, blood system disease, and neuropsychiatric disease. 7. A history of severe drug allergy. 8. Subjects receiving long-term systemic steroid therapy. 9. Subjects with ASA classification III, IV, V, VI. 10. Surgical treatment was not recommended by a physician due to the risk of medication-related osteonecrosis of the jaw (MRONJ). 11. Subject is inappropriate for participating in the research due to ethical issues.

Design outcomes

Primary

MeasureTime frame
Peri-implantitis free survival (PFS) period

Secondary

MeasureTime frame
surgical treatment time;patient reported outcome measures;peri-implantitis treatment success (Heitz-Mayfield LJ. et al. 2018);peri-implantitis progression free survival (PPFS) period;overall survival (OS) period;peri-implant probing depth;peri-implant mucosa recession;width of keratinized mucosa ;vestibule depth;modified plaque index;modified bleeding index;full mouth plaque score;bleeding on probing(BOP)

Countries

Korea, Republic of

Contacts

Public ContactHyunYoung Song

Seoul National University Dental Hospital

1030shy@naver.com+82-2-2072-3071

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026